| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurogene Inc. (NGNE) has 3 insiders with recent SEC Form 4 filings, including 27 buys and 7 sells. NGNE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.34M | $42.39M | - | |
| CFO | 98.4K | $3.10M | - | |
| Other | 12.5K | $393.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 10, 2021 | Walkey Carl94 | Senior Vice President | Sell | 3,000 | $14.20 | $42,600.00 | -0.2% | |
| Feb 5, 2021 | Walkey Carl94 | Senior Vice President | Sell | 600 | $14.00 | $8,400.00 | - | |
| Feb 3, 2021 | Walkey Carl94 | Senior Vice President | Sell | 2,400 | $13.23 | $31,752.00 | -0.2% | |
| Jul 7, 2020 | Baker Bros. Advisors LP59 | Director | Buy | 424,000 | $15.25 | $6,466,000.00 | +12.5% | |
| Apr 2, 2020 | Redmile Group, LLC | 10% Owner | Sell | 19,668 | $11.19 | $220,154.62 | -0.1% | |
| Apr 2, 2020 | Redmile Group, LLC | 10% Owner | Buy | 194,300 | $10.35 | $2,011,281.13 | +0.5% | |
| Dec 20, 2019 | Baker Bros. Advisors LP59 | Director | Buy | 3,017,542 | $8.40 | $25,347,352.80 | +26.7% | |
| Dec 20, 2019 | Drachman Jonathan G | President And CEO | Buy | 119,047 | $8.40 | $999,994.80 | +5.7% | |
| Sep 11, 2019 | Drachman Jonathan G | See Remarks | Buy | 250,000 | $3.13 | $781,746.58 | +20.9% | |
| Aug 7, 2019 | Baker Bros. Advisors LP59 | Director, 10% Owner | Buy | 371,525 | $3.00 | $1,115,615.46 | +0.7% |